$ACB

Small caps to watch: Curaleaf makes hostile bid for Aurora. Plus, Cargojet, Cineplex, AGT Food, Altius Minerals and several REITs expected to see active trading today

Curaleaf Holdings (CURA-T) announced a hostile bid for Aurora Cannabis (ACB-T) valuing the offer at US$4 per Aurora share, including 0.3463 Curaleaf shares and US$0.75 cash, a 45% premium to 30-day VWAP. Other updates: Pet Valu (PET-T) Q2 revenue $290.7M and beat; Organigram (OGI-T) Q3 revenue $105.8M beat; Cineplex (CGX-T) mixed; H&R REIT (HR-UN-T) to sell GO Residential REIT (GO-U-T) for about $6.7B; Cargojet (CJT-T) Q2 revenue $275.8M beat, adjusted EPS miss.

Original reporting
Published Aug 11, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 1:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Small caps to watch: Curaleaf makes hostile bid for Aurora. Plus, Cargojet, Cineplex, AGT Food, Altius Minerals and several REITs expected to see active trading today — source image
Decision brief

The 30-second read

$ACBBullishMed
01

Why it matters

Traders can act on (1) immediate takeover odds and premium repricing for CURA and ACB, (2) earnings-driven sentiment shifts for PET, OGI, CGX, and (3) event-driven deal positioning for HR-UN, plus (4) earnings reaction trade setup for CJT given the revenue beat but adjusted EPS miss.

02

Market read

This is a multi-catalyst day for Canadian small caps, dominated by a hostile cannabis M&A headline and several quantified earnings releases.

03

What to watch

For earnings names, adjusted metrics quality matters (e.g., Organigram’s net income boosted by non-cash fair value gains), and for Cargojet the key is whether the adjusted miss reflects sustainable margin pressure or timing.

Relevance 8/10Novelty 7/10Timing: pre-market today for several earnings prints; takeover headline is immediate

Background

The article is a small-cap watchlist updated through the day, covering one hostile takeover attempt and several pre-market earnings updates plus a major REIT asset sale.

Company-level read

Ticker impact

$ACBBullishMedium confidence
Context

Aurora is the target of Curaleaf’s hostile offer at US$4 per share, including 0.3463 Curaleaf shares and US$0.75 cash.

Expected impact

Likely upside bias with elevated volatility until Aurora responds or a formal bid process begins.

Evidence & confidence

The text discloses concrete offer terms and premium levels, but explicitly states there is no assurance the offer will be made.

$OGIBullishMedium confidence
Context

Organigram reported Q3 revenue of $105.8 million and adjusted EBITDA of $13.4 million, both ahead of expectations.

Expected impact

Potentially positive near-term price action as traders re-rate earnings power versus prior-year losses.

Evidence & confidence

The article provides specific beat figures and explains net income increase via non-cash fair value gains, which can temper quality concerns.

Market effects

Cannabis and small-cap Canadian equities may see cross-name sympathy trading on takeover premium and earnings beats/misses.

Could increase volatility in the TSX small-cap complex as multiple names report or face corporate actions on the same day.

Limited beyond North American small-cap sentiment, except for any broader cannabis M&A read-through.

Counterpoint

Hostile bids often fail or get re-priced; Aurora may resist, and the offer’s uncertainty can cap upside despite the headline premium.

Key entities

  • Curaleaf Holdings Inc.

    Announced a hostile bid for Aurora with specific per-share consideration and premium levels.

  • Aurora Cannabis Inc.

    Target of the hostile offer; deal terms and premium are disclosed in the article.

  • H&R REIT

    Agreed to sell all assets to GO Residential REIT for about $6.7 billion, expected to close in Q4.

  • GO Residential REIT

    Buyer in the H&R REIT asset sale transaction, with a pro forma ownership stake described.

Related articles

$ACBHighAI 9/10

Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry Leader

Curaleaf Holdings said it intends to launch a takeover bid for Aurora Cannabis, offering US$4.00 per Aurora share: 0.3463 Curaleaf subordinate voting shares plus US$0.75 cash. The offer implies a 45% premium to Aurora’s 30-day VWAP and 110% excluding Aurora cash. Curaleaf cites EU-GMP and distribution synergies and urges Aurora’s board to discuss.

$OGIMedAI 8/10

Organigram Reports Record Third Quarter Fiscal 2026 Results

Organigram Global Inc. (NASDAQ: OGI, TSX: OGI) reported Q3 fiscal 2026 results for the quarter ended June 30, 2026. Gross revenue rose to $145.1M (+32% YoY), net revenue to $105.8M (+49%), and adjusted EBITDA to $13.4M (+136%). Net income was $105.5M. Results were driven largely by Sanity Group GmbH, acquired April 15, 2026.

$ACBMedAI 8/10

Aurora Cannabis Announces Fiscal 2027 First Quarter Results

Aurora Cannabis (NASDAQ: ACB, TSX: ACB) reported fiscal 2027 Q1 results for the quarter ended June 30, 2026. Net revenue was $67.6 million, down from $74.1 million. International medical cannabis net revenue rose 17% to $43.3 million, while Canadian medical cannabis fell 25% to $20.7 million. The company had $149.1 million cash and no debt, and posted a $4.0 million net loss from continuing operations.

$CURLFMed

Curaleaf Holdings, Inc. (CURLF): Results of Operations and Financial Condition

Curaleaf Holdings, Inc. (CURLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226-exx994xearningsrelease.htm EX-99.1 Document Curaleaf Reports Second Quarter 2026 Results: Continued Growth, Margin Strength, and Profitability Second quarter 2026 net revenue of $340 million Second quarter 2026 International revenue of $51 million Second quarter 20